Graduate School of Peking Union Medical College, Beijing 100730, People's Republic of China.
Clin Exp Metastasis. 2011 Jan;28(1):1-12. doi: 10.1007/s10585-010-9353-9.
To investigate the relevant molecular mechanisms of platelet in promoting metastasis of tumor cell. The adhesion of fluorescence dye labeled-platelet to human liver sinusoidal endothelial cell (LSEC) line and tumor cell lines were detected by fluorescence microscope and fluorescence plate reader or laser scanning confocal microscope. The relevant adhesion molecules were analyzed by the antibody blockage experiment. The immune colloidal gold transmission electron microscope (TEM), flow cytometry and dye transfer were used to decipher the adhesion and fusion of platelet and LSEC. The tumor cells adhesion to vessels in ischemia condition was analyzed on mouse mesenteric vessels and the metastasis and neovascularization of metastatic foci in pulmonary tissue were also detected after tumor cells injected into nude mice via tail veil. After hypoxia-reoxygenation, tumor cell or LSEC markedly increased its adhesion with platelet, which could be blocked by different antibodies to platelet adhesion molecules. Platelet increased adhesion of tumor cell to LSEC in dose-dependent manner. The fusion of platelet and LSEC was demonstrated by translocation of fluorescent dye from platelet into the adherent LSEC; gpIIb emerged on the LSEC; and confirmed by TEM. The morphological examination found platelet presented between tumor cell and LSEC. Animal experiment indicated that the tumor adhesion to vessels was seldom in normal condition, but increased in ischemia-reperfusion condition, and further significantly enhanced by platelets. The number of tumor metastatic foci and the density of blood vessels within metastatic foci in lung were markedly increased by tumor cell pre-adhered with platelet. The adhesion or fusion of platelet to endothelial cell mediated by platelet surface adhesion molecules, which could promote the adhesion of tumor cell with endothelial cells and the tumor metastasis.
为了研究血小板促进肿瘤细胞转移的相关分子机制。通过荧光显微镜和荧光板读数器或激光扫描共聚焦显微镜检测荧光染料标记的血小板与人肝窦内皮细胞(LSEC)系和肿瘤细胞系的粘附。通过抗体阻断实验分析相关粘附分子。采用免疫胶体金透射电镜(TEM)、流式细胞术和染料转移法解析血小板与 LSEC 的粘附和融合。分析缺血条件下肿瘤细胞在小鼠肠系膜血管中的粘附,以及肿瘤细胞尾静脉注射裸鼠后肺组织中转移灶的转移和新生血管形成。缺氧复氧后,肿瘤细胞或 LSEC 与血小板的粘附明显增加,血小板粘附分子的不同抗体可阻断这种粘附。血小板以剂量依赖的方式增加肿瘤细胞与 LSEC 的粘附。血小板和 LSEC 的融合通过荧光染料从血小板转移到粘附的 LSEC 中证明;gpIIb 出现在 LSEC 上;并通过 TEM 证实。形态学检查发现血小板存在于肿瘤细胞和 LSEC 之间。动物实验表明,正常情况下肿瘤与血管的粘附很少,但在缺血再灌注情况下增加,并且血小板进一步显著增强。血小板预先粘附肿瘤细胞后,肺内肿瘤转移灶的数量和转移灶内血管的密度明显增加。血小板表面粘附分子介导的血小板与内皮细胞的粘附或融合,可促进肿瘤细胞与内皮细胞的粘附和肿瘤转移。